Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Coming for Care | Vaccines & Boosters | Testing | Health & Safety | Visitor Policies

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Coming for Care | Vaccines & Boosters | Testing | Health & Safety | Visitor Policies

Center for Heart & Vascular Health

Experience is What Sets Us Apart

The ChristianaCare Center for Heart & Vascular Health treats more heart and vascular cases than many U.S. hospitals. It’s this experience that makes us a national, regional and local leader for heart care.

Studies show that the more clinical procedures a hospital performs, the better the patient outcomes. So, the next time you need heart care, trust your heart to our unmatched experience and highly talented doctors.

Statistics at a glance

Last year, the ChristianaCare Center for Heart & Vascular Health performed:

Open-heart cases: 724
Ventricular Assist Device cases: 7
Transaortic valve replacement cases: 82
Cardiac-Catheterization cases: 4,673
Electrophysiology cases: 1,652
Vascular surgery cases: 1,351
Vascular intervention cases: 4,358
Neuro Intervention cases: 731
Cardiovascular non-invasive studies: 20,048
Vascular ultrasound studies: 19,667
Cardiac Rehabilitation monitored visits: 21,878